Position in AMGN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$5,973,531
+$244,358 QoQ
Shares Held
16,496
+1.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
#753
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ProVise Management Group, LLC holds $49,564,821 across 10 Drug Manufacturers - General names. AMGN ranks #3 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
134,100 | $21,016,152 | |
| 2 | GSK |
GSK plc
|
123,527 | $6,475,285 | |
| 3 | AMGN |
Amgen Inc
This page
|
16,496 | $5,973,531 | |
| 4 | SNY |
Sanofi
|
120,829 | $5,154,565 | |
| 5 | PFE |
Pfizer Inc
|
145,537 | $3,504,530 | |
| 6 | ABBV |
AbbVie Inc.
|
10,735 | $2,701,355 | |
| 7 | LLY |
ELI LILLY & Co
|
1,561 | $1,872,310 | |
| 8 | JNJ |
Johnson & Johnson
|
6,573 | $1,669,344 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,973,531 | 16,496 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $5,729,173 | 16,283 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $5,337,771 | 16,308 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $4,590,829 | 16,268 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,568,154 | 16,361 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $5,018,447 | 16,108 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $4,227,580 | 16,220 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $6,032,093 | 18,721 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5,897,181 | 18,874 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $5,468,895 | 19,235 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $6,172,844 | 21,432 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $5,862,461 | 21,813 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,916,854 | 22,146 | Shares | Sole | 2023-08-24 | |
| 2023-03-31 | $5,300,368 | 21,925 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $5,907,298 | 22,492 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $4,657,214 | 20,662 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $4,463,095 | 18,344 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $3,719,675 | 15,382 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $2,679,167 | 11,909 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $2,653,021 | 12,476 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $2,743,162 | 11,254 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $2,742,383 | 11,022 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $2,535,787 | 11,029 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $2,797,284 | 11,006 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $2,691,870 | 11,413 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $2,443,099 | 12,051 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||